Q16611 (BAK_HUMAN) Homo sapiens (Human)
Bcl-2 homologous antagonist/killer UniProtKBInterProSTRINGInteractive Modelling
Available Structures
48 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| The NMR structure of the BID-BAK complex |
Heteromer P55957; | |||||
| Assess | ||||||
| K113-Ubiquitinated BAK |
Heteromer P62979; | |||||
| Assess | ||||||
| Crystal Structure of human BAK in complex with M3W5_BID |
Heteromer P55957; | 1×CU; | ||||
| Assess | ||||||
| Bak core latch dimer in complex with Bim-h3Pc-RT |
Heteromer O43521; | 2×PO4; | ||||
| Assess | ||||||
| Bak in complex with Bim-h3Pc |
Heteromer O43521; | 2×1PG; 1×NH4; | ||||
| Assess | ||||||
| Bak core latch dimer in complex with Bim-BH3 - Cubic |
Heteromer O43521; | 1×TFA; 6×EDO; 1×CL; 1×GOL; | ||||
| Assess | ||||||
| Bak in complex with Bim-h3Glg |
Heteromer O43521; | 6×MG; 1×EDO; | ||||
| Assess | ||||||
| Bak core latch dimer in complex with Bim-h0-h3Glt |
Heteromer O43521; | 3×EDO; | ||||
| Assess | ||||||
| Bak core latch dimer in complex with Bim-RT - Tetragonal |
Heteromer O43521; | 1×MPD; 2×BR; 1×IMD; | ||||
| Assess | ||||||
| Human BAK in complex with the dF2 peptide |
Heteromer | |||||
| Assess | ||||||
| Crystal Structure of human BAK in complex with W3W5_BID |
Heteromer P55957; | |||||
| Assess | ||||||
| Human BAK in complex with the dF3 peptide |
Heteromer | |||||
| Assess | ||||||
| Human BAK in complex with the dM2 peptide |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of Bak bound to Bnip5 BH3 |
Heteromer P0C671; | |||||
| Assess | ||||||
| Crystal structure of human BAK in complex with the Pxt1 BH3 domain |
Heteromer Q8NFP0; | |||||
| Assess | ||||||
| Crystal structure of BAK in complex with inhibiting antibody 14G6 |
Heteromer | 1×SO4; 3×CCN; 3×PEG; 1×144; 2×PGE; | ||||
| Assess | ||||||
| Crystal structure of BAK L100A in complex with activating antibody fragments |
Heteromer | 3×MPD; | ||||
| Assess | ||||||
| Crystal structure of BAK-BAX heterodimer with lysoPC |
Heteromer Q07812; | 3×K6G; 1×ZN; 2×NA; 2×PEG; 2×EDO; 1×CL; | ||||
| Assess | ||||||
| Crystal structure of BAK-BAX heterodimer with C12E8 |
Heteromer Q07812; | 1×PG0; 2×PEG; 1×N8E; 1×P33; 1×PG4; | ||||
| Assess | ||||||
| A viral protein unexpectedly mimics the structure and function of pro- survival Bcl-2 |
Heteromer Q85295; | 1×NA; | ||||
| Assess | ||||||
| BakBH3 in complex with sjA |
Heteromer Q5BWX6; | |||||
| Assess | ||||||
| Crystal structure of BHRF1:Bak BH3 complex |
Heteromer P03182; | 4×NO3; 2×EDO; | ||||
| Assess | ||||||
| Crystal structure of variola virus virulence factor F1L in complex with human Bak BH3 domain |
Heteromer Q85365; | 2×CL; 1×ACT; | ||||
| Assess | ||||||
| Deerpox virus DPV022 in complex with Bak BH3 |
Heteromer Q08FX8; | 2×SO4; | ||||
| Assess | ||||||
| Vaccinia Virus F1L bound to Bak BH3 |
Heteromer O57173; | |||||
| Assess | ||||||
| Bcl-xL with Bak BH3 complex |
Heteromer Q07817; | 8×GOL; | ||||
| Assess | ||||||
| Crystal structure of human BFL-1 in complex with BAK BH3 peptide |
Heteromer Q16548; | |||||
| Assess | ||||||
| SOLUTION STRUCTURE OF AN APOPTOSIS ACTIVATING PHOTOSWITCHABLE BAK PEPTIDE BOUND to BCL-XL |
Heteromer Q07817; | 1×33B; | ||||
| Assess | ||||||
| STRUCTURE OF BCL-XL/BAK PEPTIDE COMPLEX, NMR, MINIMIZED AVERAGE STRUCTURE |
Heteromer Q07817; | |||||
| Assess | ||||||
| The X-ray Structure of a Bak Homodimer Reveals an Inhibitory Zinc Binding Site | homo-2-mer | 2×ZN; | ||||
| Assess | ||||||
| The X-ray Structure of a Bak Homodimer Reveals an Inhibitory Zinc Binding Site | homo-2-mer | 2×ZN; | ||||
| Assess | ||||||
| Human Bak Q77L | homo-2-mer | 6×ZN; | ||||
| Assess | ||||||
| Bak L100A | homo-2-mer | |||||
| Assess | ||||||
| Bak domain swapped dimer induced by BidBH3 with CHAPS | homo-2-mer | |||||
| Assess | ||||||
| Crystal Structure of human BAK in complex with WT BAK BH3 peptide | homo-2-mer | 1×CU; 1×SO4; | ||||
| Assess | ||||||
| The crystal structure of a BAK dimer activated by detergent | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of BAK core domain BH3-groove-dimer in complex with phosphatidylserine | homo-2-mer | 4×8SP; 3×SO4; | ||||
| Assess | ||||||
| Crystal structure of BAK core domain BH3-groove-dimer in complex with POPC and C8E4 | homo-2-mer | 3×SO4; 6×C8E; 3×EDO; 1×LBN; | ||||
| Assess | ||||||
| Crystal structure of BAK core domain BH3-groove-dimer in complex with DDM | homo-2-mer | 3×LMT; 6×SO4; 1×ACT; 6×EDO; | ||||
| Assess | ||||||
| Crystal structure of BAK core domain BH3-groove-dimer in complex with LysoPC | homo-2-mer | 2×K6G; 1×PG4; 4×PGE; | ||||
| Assess | ||||||
| Crystal structure of BAK core domain BH3-groove-dimer in complex with phosphatidylglycerol | homo-2-mer | 1×PG8; | ||||
| Assess | ||||||
| Bak BH3-in-Groove dimer (GFP) | homo-2-mer | 1×CAC; 1×MPD; | ||||
| Assess | ||||||
| Crystal structure of BAK core domain BH3-groove-dimer in complex with E. coli lipid | homo-2-mer | 2×PEE; | ||||
| Assess | ||||||
| BH3 domain swapped dimer of a BAK fragment | homo-2-mer | 2×SO4; 2×EPE; | ||||
| Assess | ||||||
| The crystal structure of BAK1 - a mitochondrial apoptosis regulator | monomer | 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of human Bcl-2 family protein Bak | monomer | 1×SO4; | ||||
| Assess | ||||||
| NMR structure of the Bak transmembrane helix in lipid nanodiscs | monomer | |||||
| Assess | ||||||
| NMR structure of the Bak transmembrane helix in DPC micelles | monomer | |||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7m5b.2.A | monomer | 0.81 | 98.79 | |||
| Assess | ||||||
1 SWISS-MODEL model built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 2ims.1.A | monomer | 0.67 | 86.55 | ||
| Assess | ||||||